Publication: Efficacy and safety of ibrutinib use in patients with chronic lymphocytic leukemia in real world experiences: Results of a prospective multicenter study
dc.contributor.author | Tombak, Anıl | |
dc.contributor.author | Tanrıkulu, Funda Pepedil | |
dc.contributor.author | Durusoy, Salih Sertaç | |
dc.contributor.author | Gürkan, Emel | |
dc.contributor.author | Kaya, Emin | |
dc.contributor.author | Umit, Elif G. | |
dc.contributor.author | Yavaşoğlu, İrfan | |
dc.contributor.author | Mehtap, Özgür | |
dc.contributor.author | Deveci, Burak | |
dc.contributor.author | Özcan, Mehmet Ali | |
dc.contributor.author | Terzi, Hatice | |
dc.contributor.author | Okay, Mufide | |
dc.contributor.author | Sayınalp, Nilgün | |
dc.contributor.author | Yılmaz, Mehmet | |
dc.contributor.author | Okan, Vahap | |
dc.contributor.author | Kızıklı, Alperen | |
dc.contributor.author | Özcan, Ömer | |
dc.contributor.author | Çetin, Guven | |
dc.contributor.author | Demircioglu, Sinan | |
dc.contributor.author | Aydogdu, Ismet | |
dc.contributor.author | Saydam, Guray | |
dc.contributor.author | Davulcu, Eren Arslan | |
dc.contributor.author | İlhan, Gul | |
dc.contributor.author | Ucar, Mehmet Ali | |
dc.contributor.author | Özet, Gulsum | |
dc.contributor.author | Akpinar, Seval | |
dc.contributor.author | Turgut, Burhan | |
dc.contributor.author | Berber, İlhami | |
dc.contributor.author | Kurtoglu, Erdal | |
dc.contributor.author | Sonmez, Mehmet | |
dc.contributor.author | Batur, Derya Selim | |
dc.contributor.author | Yildirim, Rahsan | |
dc.contributor.author | Özkocaman, Vildan | |
dc.contributor.author | Gunes, Ahmet Kursat | |
dc.contributor.author | Sahip, Birsen | |
dc.contributor.author | Ertop, Sehmus | |
dc.contributor.author | Akay, Meltem | |
dc.contributor.author | Basturk, Abdulkadir | |
dc.contributor.author | Dogu, Mehmet Hilmi | |
dc.contributor.author | Akdeniz, Aydan | |
dc.contributor.author | Ünal, Ali | |
dc.contributor.author | Seyhanli, Ahmet | |
dc.contributor.author | Ferhanoglu, Burhan | |
dc.contributor.buuauthor | ÖZKOCAMAN, VİLDAN | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Hematoloji Ana Bilim Dalı | |
dc.contributor.researcherid | AAH-1854-2021 | |
dc.date.accessioned | 2024-12-04T13:10:57Z | |
dc.date.available | 2024-12-04T13:10:57Z | |
dc.date.issued | 2019-11-13 | |
dc.description | Bu çalışma, 07-10 Aralık, 2019 tarihlerinde Orlando[Amerika]’da düzenlenen 61. Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Kongresi‘nde bildiri olarak sunulmuştur. | |
dc.description.sponsorship | Amer Soc Hematol | |
dc.identifier.doi | 10.1182/blood-2019-126402 | |
dc.identifier.eissn | 1528-0020 | |
dc.identifier.issn | 0006-4971 | |
dc.identifier.uri | https://doi.org/10.1182/blood-2019-126402 | |
dc.identifier.uri | https://ashpublications.org/blood/article/134/Supplement_1/5476/425188/Efficacy-and-Safety-of-Ibrutinib-Use-in-Patients | |
dc.identifier.uri | https://hdl.handle.net/11452/48891 | |
dc.identifier.volume | 134 | |
dc.identifier.wos | 000577164606194 | |
dc.identifier.wos | https://www.nature.com/articles/s41409-022-01613-w | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Amer Soc Hematology | |
dc.relation.journal | Blood | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Hematology | |
dc.title | Efficacy and safety of ibrutinib use in patients with chronic lymphocytic leukemia in real world experiences: Results of a prospective multicenter study | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Hematoloji Ana Bilim Dalı | |
relation.isAuthorOfPublication | 516d4442-e436-45a6-87b9-741a9e213d31 | |
relation.isAuthorOfPublication.latestForDiscovery | 516d4442-e436-45a6-87b9-741a9e213d31 |
Files
Original bundle
1 - 1 of 1